Cadian Capital Management, LP Guardant Health, Inc. Transaction History
Cadian Capital Management, LP
- $1.77 Billion
- Q2 2025
A detailed history of Cadian Capital Management, LP transactions in Guardant Health, Inc. stock. As of the latest transaction made, Cadian Capital Management, LP holds 3,179,217 shares of GH stock, worth $175 Million. This represents 9.36% of its overall portfolio holdings.
Number of Shares
3,179,217
Previous 4,595,087
30.81%
Holding current value
$175 Million
Previous $196 Million
15.48%
% of portfolio
9.36%
Previous 8.38%
Shares
7 transactions
Others Institutions Holding GH
# of Institutions
416Shares Held
127MCall Options Held
1.51MPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA12.2MShares$670 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$619 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA4.98MShares$274 Million0.05% of portfolio
-
Baillie Gifford & CO4.81MShares$265 Million0.2% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.25MShares$234 Million7.85% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $5.63B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...